Inactivated polio vaccine
Sponsors
PATH, Centers for Disease Control and Prevention, China National Biotec Group Company Limited, University of Bergen, GlaxoSmithKline
Conditions
HIVInfluenzaInfluenza Viral InfectionsInfluenza, HumanMalariaPolioSalmonella InfectionsTetanus
Phase 2
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
WithdrawnNCT01810731
Start: 2014-04-30End: 2014-04-30Updated: 2014-04-10
A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
RecruitingNCT06213506
Start: 2024-01-15End: 2026-04-27Target: 516Updated: 2024-01-19
Phase 4
Inactivated Influenza Vaccine Effectiveness in Tropical Africa
CompletedNCT00893906
Start: 2009-05-31End: 2013-04-30Target: 10000Updated: 2013-09-23
Immunogenicity and Safety of Sabin-IPV Replacement Vaccination
CompletedNCT04051736
Start: 2018-03-01End: 2020-08-31Updated: 2020-09-09
An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh
Active, not recruitingNCT04998344
Start: 2021-04-07End: 2024-12-31Target: 3800Updated: 2024-04-19